A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.

Duska, L R; Penson, R; Supko, J G; Finkelstein, D M; Makastorsis, T; Gallagher, J; Borden, K; Goodman, A; Fuller, A F; Nikrui, N; Seiden, M V

Duska, L R; Penson, R; Supko, J G; Finkelstein, D M; Makastorsis, T; Gallagher, J; Borden, K; Goodman, A; Fuller, A F; Nikrui, N; Seiden, M V.

Affiliation

Duska LR; Vincent Gynecology, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston 02114, USA.

Clin Cancer Res ; 5(6): 1299-305, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10389912

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Ovarian Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cohort Studies; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Female; Granulocyte Colony-Stimulating Factor/administration & dosage; Humans; Middle Aged; Ovarian Neoplasms/mortality; Paclitaxel/administration & dosage; Paclitaxel/adverse effects; Recurrence; Survival Rate; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links